Alexandria Real Estate Equities

FibroGen will pay $10M to exit HQ lease in SF’s Mission Bay

FibroGen will pay $10M to exit HQ lease in SF’s Mission Bay

Failed clinical trials push drug company to early exit from 18-year home

Developer ARE Sues NYC for EDC-Botched Life Sciences Project

Developer sues city, claims EDC botched life sciences campus project

Alexandria Real Estate Equities alleges city fraud will cost another $50 million

Amgen to sublease 100K sf of life science offices in San Carlos

Amgen to sublease 100K sf of life science offices in San Carlos

Ballooning sublease market, plus new Bay Area projects, pushes biotech vacancy to 20%